Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

2(29%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

86%

Ph early_phase_1

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Early Phase 1First-in-human

1(14.3%)

N/ANon-phased studies

6(85.7%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(5)

Detailed Status

Completed5

Active, not recruiting1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Early Phase 1

Trials by Phase

Early Phase 11 (14.3%)

N/A6 (85.7%)

Trials by Status

active_not_recruiting114%

completed571%

recruiting114%

Recent Activity

2 active trials

Showing 5 of 7

active_not_recruitingnot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT06784960Not Applicable

Communication Strategies to Increase HPV Vaccinations

Active Not Recruiting

NCT07199660Not Applicable

Reactions to Social Media Warning Labels Among Teens and Young Adults

Completed

NCT06787937Not Applicable

Communicating About Nicotine Reduction in Cigarettes

Recruiting

NCT04740008Early Phase 1

Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices

Completed

NCT04460703Not Applicable

COVID-19 Vaccine Messaging, Part 1

Completed

NCT03002324Not Applicable

Tailoring of Vaccine-Focused Messages: Disease Salience

Completed

NCT02851459Not Applicable

Tailoring of Vaccine-Focused Messages: Moral Foundations

Completed

All 7 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 7